Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

Delayed Data
As of Feb 11
 -0.24 / -0.07%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 20 analysts offering 12-month price forecasts for Regeneron Pharmaceuticals have a median target of 597.00, with a high estimate of 676.00 and a low estimate of 400.00. The median estimate represents a +62.56% increase from the last price of 367.24.

Analyst Recommendations

The current consensus among 24 polled investment analysts is to Buy stock in Regeneron Pharmaceuticals. This rating has held steady since January, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
May 05

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 11.43%
Growthannually 15.89%


Growthquarterly 11.20%
Growthannually 25.87%
Key to the earnings and sales forecast charts.